(2-hex-3-enoxy-2-oxoethyl)-dimethyl-[3-(prop-2-enoylamino)propyl]azanium
C16H29N2O3+ — CID 91322486
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2-hex-3-enoxy-2-oxoethyl)-dimethyl-[3-(prop-2-enoylamino)propyl]azanium
(2-hex-3-enoxy-2-oxoethyl)-dimethyl-[3-(prop-2-enoylamino)propyl]azanium (PubChem CID 91322486) has the molecular formula C16H29N2O3+ and a molecular weight of 297.42 g/mol. Its IUPAC name is (2-hex-3-enoxy-2-oxoethyl)-dimethyl-[3-(prop-2-enoylamino)propyl]azanium.
Molecular Properties
| Compound Name | (2-hex-3-enoxy-2-oxoethyl)-dimethyl-[3-(prop-2-enoylamino)propyl]azanium |
|---|---|
| PubChem CID | 91322486 |
| Molecular Formula | C16H29N2O3+ |
| Molecular Weight | 297.42 g/mol |
| Exact Mass | 297.22 |
| IUPAC Name | (2-hex-3-enoxy-2-oxoethyl)-dimethyl-[3-(prop-2-enoylamino)propyl]azanium |
| SMILES | C=CC(=O)NCCC[N+](C)(C)CC(=O)OCCC=CCC |
| InChI | InChI=1S/C16H28N2O3/c1-5-7-8-9-13-21-16(20)14-18(3,4)12-10-11-17-15(19)6-2/h6-8H,2,5,9-14H2,1,3-4H3/p+1 |
| InChIKey | GCCITNMLZPPMIA-UHFFFAOYSA-O |
| XLogP | 1.65 |
| TPSA | 55.40 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 297.42 |
| LogP ≤ 5 | 1.65 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91322486 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.